— McKesson Corporation (NYSE: MCK) reported third-quarter 2019 earnings of $3.60 per share, in line with the street projection.
— Total revenue grew 9% to $57.62 billion, vs $55.07 billion expected. The topline was driven by its US Pharmaceutical and Specialty Solutions segment.
— Revenues from US Pharma segment were $46.0 billion, up 10%, driven by branded pharmaceutical price increases and increased specialty pharmaceutical volumes.
— Reaffirms fiscal 2020 adjusted EPS guidance range of $14.00 – $14.60.
— CME shares have gained 0.7% immediately following the announcement.
Get access to timely and accurate verbatim transcripts that are published within hours of the event.
Most Popular
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on
Target (TGT): A look at some of the challenges faced by the retailer in 3Q24
Shares of Target Corporation (NYSE: TGT) stayed green on Thursday, recovering from the stumble it took a day ago after delivering disappointing results for the third quarter of 2024 and
